,

NDFS13 BARDA Presentation: Partnering with the Biomedical Advanced Research and Development Authority

Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures.

View Slide Deck

/0 Comments/by
You might also like
NDFS12 – Greenberg Traurig Presentation: Legal Aspects of Federal Technology Investment & Their Potential Impact on Your Intended Markets
NDFS12 – NCI Presentation: New Initiatives to Accelerate Development of Cancer Therapies in the Era of Precision Medicine
National Institute of Allergy and Infectious Disease Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Natalia KruchininNIAID at NDFS 2023, with Dr. Kruchinin
How Non-Dilutive Funding Can Extend Runway in BioPharma, Biotech, and Tech BioIs Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
NDFS17 NINDSNDFS17 Video: NINDS Funding Programs for Translational Research in Neuroscience
BARDA Coronavirus Countermeasures Portfolio
Available Online: Non-Dilutive Funding Opportunities Beyond the SBIR
Updated BARDA Funding Opportunities for Coronavirus
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *